Image Description (Chem Structure V1)
Zerviate
Product Images NDC 71776-024
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Zerviate (NDC 71776-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eyevance Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (Pouch Label)
ZERVIATE is a cetirizine ophthalmic solution used for topical ophthalmic use. Each mL contains 2.4 mg of cetirizine (equivalent to 2.85 mg cetirizine hydrochloride). The storage temperature should be between 15°-25°C (59°-77°F), and single-use vials should be stored in the original foil pouch, protected from light. The product is manufactured by Excelvision in France and comes in a package of 5 single-use vials. However, the unit is not intended for individual sale.*
Image Description (Product Carton)
ZERVIATE is a prescription medicine used to treat eye itching associated with allergic conjunctivitis. It contains 24 mg of cetirizine in each mL, in addition to inactive ingredients. It is meant for ophthalmic use only and expected to be used twice daily, one drop per affected eye. It comes in a single-use container provided in a pouch for safekeeping, and it should be stored at 15°C to 25°C.*
Image Description (Unit Label)
ZERVIATE is an ophthalmic solution containing cetirizine, which is used to treat various symptoms of allergic conjunctivitis. The brand name is Eyevance.*
Image Description (Zerviate Box Label V1)
Zerviate is a cetirizine ophthalmic solution with a strength of 0.24%. Each mL of the solution contains 2.4mg of cetirizine, which is equivalent to 2.85mg of cetirizine hydrochloride. The usual dosage is one drop in the affected eye twice daily. The solution should be stored at a temperature of 15°-25°C (59°-77°F). The inactive ingredients include benzalkonium chloride (0.01%), edetate disodium, glycerin, hypromellose, polyethylene glycol 400, polysorbate 80, sodium phosphate, dibasic, and water for injection. The product is manufactured by Renaissance Lakewood, LLC in Italy and is intended for topical ophthalmic use.*
Image Description (Zerviate Product Label V1)
Each mL of the solution contains 2.4 mq of cetirizine, equivalent to 2.85 mg cetirizine hydrochloride. It is recommended to store the solution at 15°-25°C. The solution is produced by Renaissance Lakewood, LLC and is intended for topical ophthalmic use only. The product comes in a 5mL sterile bottle with NDC 71776-024-05. There is a manufacturer's warning written in capital letters but it is not readable due to errors.*
Image Description (Zerviate Sample Label)
Zerviate is a medication in the form of cetirizine ophthalmic solution, 0.24% that is used to treat eye related allergies. It can be stored at 15°-25°C (59°-77°F) and should be kept in its original foil pouch, protected from light. Each mL of the solution contains 2.4 mg of cetirizine (equivalent to 2.85 mg cetirizine hydrochloride) and other inactive substances such as Benzalkonium chloride and glycerin. The solution is manufactured by Excelvision in France and distributed by Eyevance Pharmaceuticals, LLC, in the United States. The usual dosage is one drop in the affected eye twice daily.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
